LOX and congenital bilateral aplasia of vas deferens from CFTR mutation: Moreover, LOX has been recognized as a source of vascular oxidative stress [16] and a pivotal player in CVC whose expression is upregulated in both CAVD and calcified atherosclerotic lesions as well as in calcifying VSMCs and VICs [12].